Joinn Laboratories(China)Co.,Ltd.
603127
Rank in Stocks
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Share Price
$6.82
Market Cap
$4.30B
Change (1 day)
-6.30%
Change (1 year)
184.21%
Country
CN
Trade Joinn Laboratories(China)Co.,Ltd. (603127)
Category
Healthcare
Stock price history for Joinn Laboratories(China)Co.,Ltd. (603127)
Highest end of day price: $3.68 on 2026-10-01
Lowest end of day price: $6.48 on 2021-02-01
Lowest end of day price: $6.48 on 2021-02-01
Stock price history of Joinn Laboratories(China)Co.,Ltd. from 2021 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 11.18% |
| 2025 | 111.15% |
| 2024 | -23.74% |
| 2023 | -55.34% |
| 2022 | -30.77% |
| 2021 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $681.96 | 20.23% |
US
|
|
| $230.78 | 5.81% |
US
|
|
| $385.71 | 105.14% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $172.55 | 18.29% |
US
|
